Clinical trial
Insulin Glargine in Type 2 Diabetes Mellitus
NCT00311818 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00311818 |
|---|---|
| Title | Insulin Glargine in Type 2 Diabetes Mellitus |
| Official title | 44-week, Parallel, Open, Randomized, Multinational, Multi-center Clinical Trial to Compare Efficacy and Safety of the Combination Therapy of an Oral Anti-diabetic Drug Treatment With Either HOE901 Insulin Once Daily or Lispro Insulin Analogue at Mealtime in Type 2 Diabetes Mellitus Patients Poorly… |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Insulin glargine |
| Start date | Jun 1, 2003 |
| Primary completion | May 1, 2005 |
| First posted | Apr 6, 2006 |
| Last update posted | Sep 15, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: